Sphingolipids, which have been considered only as structural elements of the cell membrane, are now recognized as a new group of intracellular second messengers (1, 2) . We found that sphingomyelin levels transiently decreased and concomitantly ceramide increased when human leukemia HL-60 cells were treated with 1␣,25-dihydroxyvitamin D 3 to differentiate into monocytic cells and that synthetic cell-permeable ceramide could induce monocytic differentiation of HL-60 cells (3, 4) . A new signal transduction pathway termed "sphingomyelin cycle" was proposed by our group and subsequently similar sphingomyelin hydrolysis was reported to be induced by many other cytokines, including tumor necrosis factor-␣ (TNF-␣), 1 ␥-interferon (5, 6), interleukin-1 (7, 8) , and nerve growth factor (9), and by cross-linking of Fas (10) . Ceramide, a product of sphingomyelin hydrolysis, is postulated as an intracellular mediator of apoptosis, because it was shown to induce DNA fragmentation and typical morphological change to apoptosis following the inhibition of cell growth (11, 12) .
To exert its biological effects, ceramide seems to transduce the intracellular signals by activating protein kinase(s) (13, 14) or protein phosphatase(s) (15, 16) and by inducing the downregulation of c-myc (5) and the activation of nuclear translocation of nuclear factor NF-B (17) (18) (19) . The proto-oncogene c-jun encodes another transcription factor that is a component of AP-1 (reviewed in Ref. 20) . c-Jun is a member of the bZip transcription factor family and possesses a basic DNA-binding domain and a leucine-zipper dimerization motif (21) . The c-Jun homodimers or the heterodimers with c-Jun and c-Fos family members bind to the DNA consensus sequence TGA(C/G)TCA (called the 12-o-tetradecanoylphorbol 13-acetate-responsive element) found in the promoter regions of several genes. Induction of the c-jun gene is an early response event during activation of quiescent fibroblasts by serum (22, 23) or mitogens such as phorbol esters (24) . Furthermore, c-jun gene expression is induced by cytokines including TNF-␣ (25) , nerve growth factor (26) , and interleukin-1 (27) . Induction of c-jun during cell differentiation is also reported (28 -31) . Recent studies have demonstrated that c-jun expression is induced by apoptosis-inducing agents such as ionizing radiation (32) , UV light (33) , and cytotoxic drugs including etoposide (34), 1-␤-D-arabinofuranosylcytosine (35, 36) , and cis-diamminedichloroplatinum (II) (37) or by growth factor deprivation (38) . These and other data (39 -42) suggest that c-jun/AP-1 is a very important factor in the regulation of cell growth, differentiation, and apoptosis.
In this study, we examined whether ceramide induces c-jun/ AP-1 activation and whether its activation is required for the induction of apoptosis by ceramide in human leukemia HL-60 cells, because c-jun/AP-1 activation seems to play a role in inducing apoptosis as well as other early responsive genes such as NF-B and c-myc. Our results show that c-jun/AP-1 is activated by ceramide in the early process of apoptosis and that the impairment of AP-1 rescues apoptosis. These data suggest that ceramide is crucially involved in the signal transduction pathway leading to apoptosis through the activation of c-jun/AP-1.
containing 10% heat-inactivated fetal bovine serum and 80 mg/liter kanamycin at 37°C in a humidified atmosphere of 5% CO 2 . Before the experiments, the cells were washed with RPMI 1640 medium containing transferrin (5 mg/liter) and insulin (5 mg/liter) instead of serum and incubated overnight in the serum-free medium at a concentration of 5 ϫ 10 5 /ml if not described particularly. Northern Blot Analysis-Total cellular RNA was isolated using ISO-GEN (Nippon Gene) according to the manufacturer's protocol. Northern blotting was performed as described previously (43) . Human c-jun oligonucleotide probe (Oncogene Science) was 5Ј-end labeled with a Kination kit (Toyobo Co., Ltd). Briefly, 4 pmol of oligonucleotide was mixed with 1 l of 10 ϫ protruding end kinase buffer and 5 l of [␥- 32 P]ATP, incubated at 37°C for 30 min, and then purified through Sephadex G-25 spun column twice. Hybridizations were performed at 42°C for 24 h, and then the membranes were washed in 2 ϫ SSC/0.1% SDS (1 ϫ SSC, 0.15 M Nacl, 15 mM sodium citrate) at room temperature for 30 min and at 50°C for 20 min. The membranes were exposed to Fuji x-ray films with intensifying screens at Ϫ80°C for 2 days. Equal loading of RNA was confirmed by methylene blue staining of the membrane.
Nuclear Run-on Assay-Nuclear run-on assay was performed as described (28) with modification. The cells (5 ϫ 10 7 ) were collected, resuspended in 4 ml of ice-cold lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl 2 , 0.5% Nonidet P-40), and vortexed gently for 20 s and left on ice for 5 min. Nuclei were pelleted by centrifugation at 500 ϫ g for 5 min and resuspended in 100 l of glycerol buffer (50 mM Tris-HCl, pH 8.3, 40% glycerol, 5 mM MgCl 2 , 0.1 mM EDTA). An equal volume of reaction buffer (100 mM KCl, 0.5 mM each of ATP, CTP, and GTP) was added to the nuclear suspension, and the reaction mixture was incubated with 100 Ci of [␣- 32 P]UTP (3000 Ci/mmol) at 26°C for 30 min. Then the reaction was terminated by the addition of 100 l of stop buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 100 mM NaCl, 20 mM MgCl 2 , 150 units/ml RNasin, 40 units/ml DNase) and incubated at 28°C for 15 min. Then proteinase K (750 g/ml) and 1% SDS were added and incubated at 37°C for 30 min. RNA was isolated by phenol/ chloroform extractions and precipitated in ethanol and 2.5 M ammonium acetate. RNA was further purified through a Sephadex G-50 spun column equilibrated and eluted with column buffer (0.3 M NaCl, 0.1% SDS, 1 mM EDTA, 10 mM Tris-HCl, pH 7.5).
Rat c-jun cDNA (obtained from RIKEN DNA Bank, Japan) or ␤-actin cDNA (2.5 g each) was denatured in 100 l of 0.1 N NaOH for 30 min, neutralized by the addition of an equal volume of buffer containing 0.5 M Tris-HCl, pH 7.0 and 3 M NaCl, and then blotted onto nylon membrane (Biodyne, Pall Corp.) using a slot-blot apparatus (Schleicher & Schuell). The membrane was prehybridized in 5 ϫ Denhardt's solution, 40% formamide, 4 ϫ SSC, 5 mM EDTA, 0.4% SDS, and 100 g/ml yeast tRNA at 42°C for 2 h. Hybridization was performed with 10 7 cpm of 32 P-labeled RNA/ml of hybridization buffer at 42°C for 72 h. Then the membrane was washed in 2 ϫ SSC with 0.1% SDS at 37°C for 30 min, 10 g/ml RNase A in 2 ϫ SSC at 37°C for 30 min, and 0.1 ϫ SSC with 0.1% SDS at 42°C for 30 min. Autoradiography was performed with intensifying screens at Ϫ80°C for 5-14 days.
Nuclear Extract Preparation-Nuclear extracts were prepared as previously described (44) with modification. Briefly, 5 ϫ 10 6 cells were collected, washed once in phosphate-buffered saline, resuspended in 400 l cold buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 3 mM MgCl 2 , 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride), allowed to swell for 15 min on ice, and then lysed by gently passing through a 27-gauge needle. The nuclei were collected by centrifugation at 400 ϫ g for 5 min and resuspended in 50 l of buffer C (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride). The tube was vigorously rocked on a shaking platform at 4°C for 30 min and centrifuged at 12,000 ϫ g for 5 min at 4°C, and the supernatant was used as the nuclear extract. The protein concentration of the extract was determined by using the BioRad protein assay.
Electrophoretic Mobility Shift Assay-Nuclear extract (6 g) was mixed with 4 g of poly(dI⅐dC)⅐poly(dI⅐dC) (Pharmacia Biotech Inc.) in a binding buffer (5 mM HEPES, pH 7.9, 5 mM MgCl 2 , 50 mM KCl, 1 mM dithiothreitol, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride; final volume, 20 l) for 10 min on ice. AP-1 consensus oligonucleotide (5Ј-CGCTTGATGACTCAGCCGGAA-3Ј) (Santa Cruz Biotechnology, Inc.) was 5Ј-end labeled as described above. The labeled probe (2.5 ϫ 10 4 cpm) was added, and the reaction mixture was incubated for 30 min on ice. Then the samples were separated by 4% native polyacrylamide gel electrophoresis in 1 ϫ TAE buffer (0.04 M Tris-acetate, 0.001 M EDTA). The gel was dried under vacuum and subjected to autoradiography overnight at Ϫ80°C. Competition studies were performed by adding 10-or 50-fold molar excess of unlabeled AP-1 consensus oligonucleotide or AP-1 mutant oligonucleotide (5Ј-CGCTTGATGACTTGGCCGGAA-3Ј) (Santa Cruz Biotechnology, Inc.) or Sp1 consensus oligonucleotide (5Ј-ATTCGATCGGGGCGGGGCGAGC-3Ј) (Promega).
Western Blot Analysis-Cells were suspended in lysis buffer containing 50 mM Tris-HCl, pH 7.6, 0.5% Triton X-100, 300 mM NaCl, 5 mM EDTA, 10 g/ml leupeptin, 10 g/ml aprotinin, and 0.5 mM phenylmethylsulfonyl fluoride. After incubation on ice for 30 min, the lysates were centrifuged at 10,000 ϫ g for 10 min, and the supernatants were recovered. The supernatants were boiled in SDS-containing sample buffer and subjected to SDS-polyacrylamide gel electrophoresis (46) . Separated proteins were electroblotted to Immobilon polyvinylidene difluoride transfer membrane (Millipore). c-Jun was detected by ECL Western blotting detection system (Amersham Corp.) using anti-c-jun/ AP-1 (N) antibody (Santa Cruz Biotechnology).
Oligonucleotides-c-jun antisense (5Ј-CGTTTCCATCTTTGCAGT-3Ј) and sense (5Ј-ACTGCAAAGATGGAAACG-3Ј) oligonucleotides corresponding to the first 18 bases after the AUG sequence of c-jun mRNA in the phosphorothioate modified condition were synthesized or obtained from BioServe Biotechnologies, MD.
Analysis of DNA Fragmentation-DNA was isolated by using a GE-NOME kit (Bio 101, CA), electrophoresed through 3% NuSieve agarose (FMC BioProducts) mini-gel in 1 ϫ TAE buffer at 50 V for 1.5 h and visualized under UV light after ethidium bromide staining. ing to c-jun mRNA molecular sizes, and the elevation of c-jun mRNA began to be detected 30 min after the addition of C 2 -ceramide. Maximal induction of c-jun expression was achieved at 1 h, and then the levels of c-jun mRNA decreased gradually to the basal level 4 h after C 2 -ceramide addition. Induction of c-jun expression by C 2 -ceramide (1-10 M) was in a dose-dependent manner (Fig. 1B) . These concentrations, at which cjun mRNA increased, correspond to those at which ceramide induces its biological effects, such as growth inhibition and apoptosis. Although a 15-fold increase in c-jun expression was induced by 10 M C 2 -ceramide 1 h after treatment, HL-60 cells began to die within 2 h and completely died 24 h after treatment with 10 M C 2 -ceramide. In most following experiments, a C 2 -ceramide concentration of 5 M or less was therefore used to detect the biological effects of C 2 -ceramide after a long term treatment.
A previous report (45) showed the specificity of biological activity of ceramide compared with dihydroceramide whose chemical structure is the same as that of ceramide except for the lack of a double bond between the fourth and fifth carbons. We found that 5 M C 2 -dihydroceramide failed to induce apoptosis and that the increase of c-jun expression by 5 M C 2 -dihydroceramide was approximately one-third of 5 M C 2 -ceramide or corresponding to the effect of 1 M C 2 -ceramide (Fig.  1C) , which could not induce apoptosis, when measured by the densitometer (data not shown). It is clearly shown that C 2 -ceramide with biological effects in HL-60 cells but not C 2 -dihydroceramide induced a significant increase of c-jun mRNA.
Regulation of c-jun Induction by Ceramide at Both Transcriptional and Post-transcriptional Levels-Next, we examined whether ceramide induced c-jun expression by a transcriptional or post-transcriptional mechanism. Actinomycin D and cycloheximide were used as inhibitors of RNA transcription and protein synthesis, respectively. As shown in Fig. 2A , the treatment with actinomycin D completely inhibited c-jun expression, whereas cycloheximide, which itself slightly increased c-jun mRNA, superinduced c-jun expression when treated with ceramide. A nuclear run-on assay showed that 5 M C 2 -ceramide increased the rate of c-jun transcription (Fig.  2B ). As shown in Fig. 2C , an approximately 4-fold increase of c-jun transcription level was found by treatment with ceramide compared with the control when the increase rate was generalized by the transcriptional level of ␤-actin, which is recognized as a housekeeping gene. We confirmed that the levels of ␤-actin mRNA did not change significantly in our experimental condition (Fig. 2D) . These studies suggested that c-jun induction by ceramide is regulated at both transcriptional and posttranscriptional levels.
AP-1 DNA Binding Activity Induced by Ceramide-Because induction of c-jun mRNA does not always mean the activation of AP-1 (42), we examined whether AP-1 DNA binding activity was increased by ceramide. By the electrophoretic mobility shift assay (Fig. 3) , we found that C 2 -ceramide increased the binding of the nuclear extract to synthetic oligonucleotides containing AP-1 consensus sequence. As shown in Fig. 3A , the prominent increase of AP-1 DNA binding activity was detected 1 h after treatment with 5 M C 2 -ceramide, and the activity was still elevated after 4 h. Competition studies were performed to confirm the specificity of the binding complexes (Fig.  3B) . By addition of 10-or 50-fold molar excess of unlabeled AP-1 consensus oligonucleotides, AP-1 complex induced by ceramide disappeared. On the other hand the addition of 10-fold molar excess of unlabeled oligonucleotides containing AP-1 mutant sequence or Sp1 consensus sequence did not affect the binding ability. Although 50-fold molar excess of those seemed to slightly decrease the binding, it may be because of nonspe- (Fig. 4A) . As shown in Fig. 4B , the viable cell number treated with 2 M ceramide, 0.5 M curcumin, and both 2 M ceramide and 0.5 M curcumin were 2.6 ϫ 10 5 /ml, 3.5 ϫ 10 5 /ml, and 3.5 ϫ 10 5 /ml, respectively, on day 3. These results showed that the growth inhibition induced by C 2 -ceramide was recovered to the levels treated with curcumin alone when the cells were treated with ceramide and curcumin. Therefore, we next investigated whether the growth recovery by curcumin meant a rescue from apoptosis. Assay of DNA fragmentation, a characteristic of apoptosis, was performed 3 h after treatment with ceramide or both ceramide and curcumin (Fig. 4C) . Curcumin alone did not induce DNA fragmentation at concentrations up to 2 M. Addition of only 0.5 M curcumin inhibited DNA fragmentation induced by 4 M C 2 -ceramide.
In another experiment, we used antisense c-jun oligonucleotides instead of curcumin in order to further confirm the role of c-jun/AP-1 in the induction of apoptosis (38) . HL-60 cell growth was little affected by antisense or sense c-jun oligonucleotides alone (data not shown). As shown in Fig. 5A , the treatment with 8 M ceramide in serum-containing medium showed about 65% of growth inhibition compared with the control on day 2. When the cells were treated with both ceramide and antisense c-jun oligonucleotides, the growth recovered according to the increase of oligonucleotide concentrations. By the treatment with 50 g/ml antisense c-jun, the viable cell numbers treated with 8 M C 2 -ceramide increased from 2.7 Ϯ 0.3 ϫ 10 5 /ml to 7.3 Ϯ 1.0 ϫ 10 5 /ml, whereas the number of the control was 7.5 Ϯ 0.5 ϫ 10 5 /ml (Fig. 5A) . Sense c-jun oligonucleotides, however, did not rescue the growth inhibition induced by ceramide. Moreover, DNA fragmentation induced by 20 M C 2 -ceramide in serum-containing medium was partially inhibited when the cells were treated with 50 g/ml antisense c-jun oligonucleotides for 2 days before treatment with C 2 -ceramide, and pretreatment with sense c-jun oligonucleotides had no significant effect on ceramide-induced DNA fragmentation (Fig. 5B) . These results strongly suggest that ceramide-induced apoptosis in HL-60 cells is inhibited by blocking AP-1 signal. In other words, AP-1 activation seems to be required in the early process of signal transduction for inducing apoptosis by ceramide in human leukemia HL-60 cells.
DISCUSSION
Sphingolipids and sphingolipid breakdown products are emerging as a new class of bioactive molecules that affect cell growth, differentiation, and apoptosis (1, 2) . The sphingomyelin cycle was discovered in HL-60 human myelogenous leukemia cells in response to 1␣,25-dihydroxyvitamin D 3 (3, 4) . Briefly, 1␣,25-dihydroxyvitamin D 3 induced the hydrolysis of sphingomyelin with the concomitant generation of ceramide through the activation of neutral and cytosolic sphingomyelinase (49) . TNF-␣ was also found to induce the sphingomyelin cycle (5, 6) and to activate the transcription factor NF-B (12) (13) (14) . Several studies support the idea that ceramide is a biological second messenger for apoptosis and that it mediates some effects through nuclear factor(s). Although c-Jun/AP-1 is an important transcription factor as well as NF-B (20) and the expression of c-jun gene is induced by serum, phorbol esters, or several cytokines including TNF-␣ (22) (23) (24) (25) (26) (27) , the relation between AP-1 and ceramide in apoptosis has not been described.
In this study, we demonstrated that ceramide could induce c-jun expression and activate AP-1 binding activity. Although in our study c-jun is transiently induced by C 2 -ceramide as shown in Fig. 1A , TNF-␣ induced prolonged activation of c-jun expression (25) . The reason for the different time course of c-jun induction between ceramide and TNF-␣ is unclear, but it may be due to the difference of the cell type or to the complexity of AP-1 dimer formation corresponding to multiple functions of TNF-␣. TNF-␣ was reported to activate sphingomyelin cycle to generate ceramide and AP-1 binding activity, respectively (41) . On the other hand, here we have shown that ceramide induced c-jun expression and AP-1 binding activity in HL-60 cells. These results suggest that in some functions of TNF-␣, including the induction of apoptosis, ceramide may be the intracellular signal to activate AP-1.
The pathway of c-jun/AP-1 activation by ceramide remains to be examined. Among many kinds of serine/threonine kinases, MAP kinase was reported to be activated by ceramide (50) . Recently, the existence of another MAP kinase family termed JNK (c-Jun N-terminal kinase) has been reported (51, 52) . JNK, not MAP kinase, can stimulate c-Jun transcriptional activity by N-terminal phosphorylation (53) . These and our studies suggest to us the idea that ceramide may mediate the signal transduction to induce apoptosis by the activation of AP-1 through JNK, because TNF-␣ and UV light, which seemed to increase intracellular ceramide levels, have been shown to activate JNK (52, 54) . However, as an effector of ceramide signal a novel serine/threonine kinase(s) (13, 14) and phosphatase(s) (15, 16) were also proposed. Although the involvement of those enzymes in c-jun induction by ceramide has not been eliminated, at least serine/threonine phosphatase(s) may not play a role because 10 ng/ml okadaic acid, a potent inhibitor of protein phosphatase 1 and 2A, did not inhibit the increase of c-jun mRNA. 2 Moreover, the involvement of protein tyrosine kinase(s) and phosphatase(s) in ceramide-induced signals also remained to be clarified. AP-1 has been shown to have multiple functions in cellular regulation including proliferation (39, 41) , differentiation (40) , and apoptosis (38) . To confirm the requirement of AP-1 activation for apoptosis by ceramide, in this work we used curcumin, 1,7-bis[4-hydroxy-3-methoxy-phenyl]-1,6-heptadiene-3,5-dione, and antisense c-jun oligonucleotide as specific inhibitors of c-jun/AP-1. Curcumin was reported to possess an inhibitory effect on 12-o-tetradecanoylphorbol 13-acetate-induced AP-1 activity (47). We found that curcumin actually decreased the protein level of c-Jun (Fig. 4A) and demonstrated that the ceramide-induced growth inhibition was recovered following the inhibition of DNA fragmentation by curcumin (Fig. 4, B and  C) . Moreover, antisense c-jun oligonucleotide prevented the growth inhibition and DNA fragmentation induced by C 2 -ceramide (Fig. 5, A and B) . These data indicate that inhibition of c-jun/AP-1 blocks the growth inhibitory effect of C 2 -ceramide. In other words, C 2 -ceramide seems to induce, at least in part, apoptosis via activation of c-jun/AP-1 in HL-60 cells. c-jun oligonucleotides protect cells from apoptosis induced by growth factor deprivation. In their experiments it was unknown what kind of intracellular signals were involved in between growth factor deprivation and c-jun induction. For the first time we here reported that ceramide is an intracellular physiological molecule to transduce an apoptotic signal through AP-1.
It has been recently shown that sphingosine 1-phosphate, a metabolite of sphingolipids, stimulates AP-1 DNA binding activity in quiescent Swiss 3T3 fibroblasts (55). In the above report, DL-threo-dihydrosphingosine, a competitive inhibitor of sphingosine kinase, inhibited AP-1 DNA binding activity induced by sphingosine. Because ceramide could be converted to sphingosine by ceramidase and further converted to sphingosine 1-phosphate by sphingosine kinase, we checked the effect of DL-threo-dihydrosphingosine on ceramide-induced c-jun expression. We found that DL-threo-dihydrosphingosine rather increased c-jun expression, 2 suggesting that sphingosine 1-phosphate is not involved in c-jun induction by ceramide. Moreover, we previously reported that C 2 -ceramide was not converted to sphingosine in HL-60 cells within 1 h (4), suggesting that ceramide exerted the effect without converting to sphingosine or sphingosine 1-phosphate.
In the present work, we demonstrated that ceramide induced apoptosis through the activation of c-jun/AP-1. Because the AP-1 complex may have different functions according to the different components (Jun, JunB, JunD, Fos, FosB, etc.), further study on the components of AP-1 activated by ceramide and the relationship between the composition and function of AP-1 complex will be required.
